SCHEMBL3293497

SCHEMBL3293497

ClC(Cl)(Cl)c1cnccn1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 1/20 0.47
HSP90AA1 P07900 1/20 0.40
KDM4E B2RXH2 5/20 0.39
NAPRT Q6XQN6 1/20 0.39
HCAR2 Q8TDS4 1/20 0.39
ADORA3 P0DMS8 1/20 0.38
TSHR P16473 1/20 0.38
MC4R P32245 1/20 0.38
ADRA1A P35348 1/20 0.38
MC3R P41968 1/20 0.38
MCL1 Q07820 1/20 0.38
NPC1 O15118 7/20 0.35
RAB9A P51151 7/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
CYP1A2 P05177 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2C19 P33261 1/20 0.34
HDAC3 O15379 1/20 0.33
HDAC1 Q13547 1/20 0.33
HDAC2 Q92769 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28453438 0.80 CYP19A1 (0.44) CYP19A1HSP90AA1KDM4ENAPRTHCAR2
SCHEMBL5720338 0.76 CYP19A1 (0.44) CYP19A1HSP90AA1KDM4ENAPRTHCAR2
SCHEMBL11261869 0.75 CYP19A1 (0.41) CYP19A1HSP90AA1KDM4ECYP1A2CYP2C19
SCHEMBL11263713 0.74 CYP19A1 (0.37) CYP19A1KDM4ECYP1A2CYP2C19
SCHEMBL29526853 0.74 TRPV4 (0.44) CYP19A1HSP90AA1KDM4ENAPRTHCAR2
SCHEMBL179284 0.74 CYP19A1 (0.42) CYP19A1HSP90AA1KDM4ENAPRTHCAR2
SCHEMBL31256061 0.74 CYP19A1 (0.42) CYP19A1HSP90AA1KDM4ENAPRTHCAR2
SCHEMBL631338 0.74 TRPV4 (0.44) CYP19A1HSP90AA1KDM4ENAPRTHCAR2
SCHEMBL28423816 0.72 CYP19A1 (0.38) CYP19A1HSP90AA1KDM4ENAPRTHCAR2
SCHEMBL11249250 0.71 KDM4E (0.39) CYP19A1KDM4ENAPRTHCAR2ADORA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-61151187-A None JP disclosed
US-12612548-B2 Method for producing inorganic fluoride luminescent material NICHIA CORPORATION (JP) 2026-04-28 US disclosed
US-20230220275-A1 METHOD FOR PRODUCING INORGANIC FLUORIDE LUMINESCENT MATERIAL NICHIA CORPORATION (JP) 2023-07-13 US disclosed
US-20230142294-A1 PRODUCTION METHOD OF INORGANIC FLUORIDE LUMINESCENT MATERIAL NICHIA CORPORATION (JP) 2023-05-11 US disclosed
WO-2021241376-A1 METHOD FOR PRODUCING INORGANIC FLUORIDE LUMINESCENT MATERIAL 日亜化学工業株式会社 2021-12-02 WO disclosed
WO-2021241375-A1 PRODUCTION METHOD OF INORGANIC FLUORIDE LUMINESCENT MATERIAL 日亜化学工業株式会社 2021-12-02 WO disclosed
CN-101195672-B Method for producing olefin-copolymerization catalyst and method for producing olefin-copolymers SUMITOMO CHEMICAL CO 2011-07-06 CN disclosed
US-7732540-B2 Process for producing olefin copolymerization catalyst and process for producing olefin copolymer SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-06-08 US disclosed
US-20090018012-A1 Process for Producing Olefin Copolymerization Catalyst and Process for Producing Olefin Copolymer SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-01-15 US disclosed
CN-101195672-A Method for producing olefin-copolymerization catalyst and method for producing olefin-copolymers SUMITOMO CHEMICAL CO (JP) 2008-06-11 CN disclosed
EP-1072576-B1 FLUORINATING AGENT, PROCESS FOR PRODUCING THE SAME, AND USE THEREOF MITSUI CHEMICALS INC (JP) 2006-08-02 EP disclosed
US-6417361-B1 HYDROGEN FLUORIDE AND N,N'-DIALKYLCYCLIC UREA COMPOUND MITSUI CHEMICALS, INC. (JP) 2002-07-09 US disclosed
CN-1294568-A Fluorinating agent, process for producing same, and use thereof MITSUI CHEMICALS INC (JP) 2001-05-09 CN disclosed
EP-1072576-A1 FLUORINATING AGENT, PROCESS FOR PRODUCING THE SAME, AND USE THEREOF Mitsui Chemicals, Inc. (JP) 2001-01-31 EP disclosed
JP-S61151187-A 2-(5-TRANS-ALKYL-1,3-DIOXAN-2-YL)-5-ALKOXYPYRAZINE UBE IND LTD 1986-07-09 JP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12612548-B2 Method for producing inorganic fluoride luminescent material FLNA, F7, NPM1 CYP19A1 3415/4885HSP90AA1 4246/4885KDM4E 2254/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.